Advertisement

Lupus Erythematosus and Lupus Anticoagulant

  • Kurt Benirschke
  • Peter Kaufmann

Abstract

Systemic lupus erythematosus (SLE) occurs primarily in young women, and it often complicates pregnancy. It has been speculated that this autoimmune disorder is so much more common in women than in men (10:1) because of their sensitization to nuclear antigens to which they are exposed during menstruation (Dameshek, 1958; Grimes et al., 1985; Hulka, 1985). Estrogens exacerbate the disease because they have a “potent influence on the immune system and therefore an effect on disease processes” (Hays-lett & Reece, 1985). Hayslett and Reece reviewed reports of the influence of pregnancy on the course of SLE and found that in 25 to 50% of patients with SLE the disease exacerbates or relapses with pregnancy. In addition, their review indicated that fetal survival is reduced because of an increased number of abortions, maternal renal insufficiency, and placental pregnancy complications. They suggested treatment regimens for women with SLE and pregnancy.

Keywords

Systemic Lupus Erythematosus Fetal Death Lupus Anticoagulant Anticardiolipin Antibody Congenital Heart Block 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramowsky, C.R., Vegas, M.E., Swinehart, G., and Gyves, M.T.: Decidual vasculopathy of the placenta in lupus erythematosus. N. Engl. J. Med. 303:668–672, 1980PubMedCrossRefGoogle Scholar
  2. Averbuch, M., Koifman, B., and Levo, Y.: Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus. Am. J. Med. 293:2–5, 1987.CrossRefGoogle Scholar
  3. Beck, I.S., Oakley, C.L., and Rowell, N.R.: Transplacental passage of antinuclear antibody. Arch. Dermatol. 93:656–663, 1966.PubMedCrossRefGoogle Scholar
  4. Bendon, R.W., Wilson, J., Getahun, B., and Bel-Kahn, J.v.d.: A maternal death due to thrombotic disease associated with anticardiolipin antibody. Arch. Pathol. Lab. Med. 111:370–373, 1987.PubMedGoogle Scholar
  5. Benirschke, K., and Driscoll, S.G.: The Pathology of the Human Placenta. Springer-Verlag, New York, 1967.Google Scholar
  6. Bennett, R.M., Peller, I.S., and Merritt, M.M.: Defective DNA-receptor function in systemic lupus erythematosus and related diseases: evidence for an autoantibody influencing cell physiology. Lancet 1:186–188, 1986.PubMedCrossRefGoogle Scholar
  7. Blackburn, W.R., Kaplan, H.S., and McKay, D.G.: Morphologic changes in the developing rat placenta following prednisolone administration. Am. I Obstet. Gynecol. 92:234–246, 1965.Google Scholar
  8. Bowie, E.J., Thompson, J.H., Pascuzzi, C.A., and Owen, C.A.: Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. I Lab. Clin. Med. 62:416–430, 1963.Google Scholar
  9. Branch, D.W., Scott, J.R., Kochenour, N.K., and Hersh-gold, E.: Obstetric complications associated with the lupus anticoagulant. N. Engl. I Med. 313:1322–1326, 1985.CrossRefGoogle Scholar
  10. Branch, D.W., Andres, R., Digre, K.B., Rote, N.S., and Scott, J.R.: The association of antiphospholipid antibodies with severe preeclampsia. Obstet. Gynecol. 73:541–545, 1989.PubMedGoogle Scholar
  11. Brandt, I.T., Triplett, D.A., Musgrave, K., and Orr, C.: The sensitivity of different coagulation reagents to the presence of lupus anticoagulants. Arch. Pathol. Lab. Med. 111:120–124, 1987.PubMedGoogle Scholar
  12. Bresnihan, B., Grigor, R.R., Oliver, M., Lewkonia, R.M., Hughes, G.R.V., Lovins, R.E., and Faulk, W.P.: Immunological mechanism for spontaneous abortion in systemic lupus erythematosus. Lancet 2:1205–1207, 1977.CrossRefGoogle Scholar
  13. Cariou, R., Tobelem, G., Soria, C., and Caen, J.: Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N. Engl. I Med. 314:1193–1194, 1986.CrossRefGoogle Scholar
  14. Carreras, L.O., Defreyn, G., Machin, S.J., Vermylen, J., Deman, R., Spitz, B., and Assche, A.v.: Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1:244–246, 1981a.PubMedCrossRefGoogle Scholar
  15. Carreras, L.O., Vermylen, J., Spitz, B., and Assche, A.v.: “Lupus” anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br. I Obstet. Gynaecol. 88:890–894, 1981b.CrossRefGoogle Scholar
  16. Carreras, L.O., Perez, G.N., Vega, H.R., and Casavilla, F.: Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 2:393–394, 1988.PubMedCrossRefGoogle Scholar
  17. Cruveiller, J., Harpey, J.-P., Vernon, P., Cannat, A., Delattre, A., Hervet, E., Lafourcade, J., and Turpin, R.: Lupus érythémateux systémique: transmission de manifestations cliniques et de facteurs biologiques de la mère au nouveu-né. Arch. Fr. Pediatr. 27:195–209, 1970.PubMedGoogle Scholar
  18. Dameshek, W.: Systemic lupus erythematosus: a complex auto-immune disorder? Ann. Intern. Med. 48: 707–730, 1958.PubMedCrossRefGoogle Scholar
  19. De Wolf, F., Carreras, L.O., Moerman, P., Vermylen, J., Assche, A.v., and Renaer, M.: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and lupus anticoagulant. Am. I Obstet. Gynecol. 142:829–834, 1982.Google Scholar
  20. Druzin, M.L., Lockshin, M., Edersheim, T.G., Hutson, I.M., Krauss, A.L., and Kogut, E.: Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am. I Obstet. Gynecol. 157:1503–1510, 1987.Google Scholar
  21. El-Roeiy, A., Myers, S.A., and Gleicher, N.: The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet. Gynecol. 75:390–396, 1990.PubMedGoogle Scholar
  22. Farquharson, R.G., Compston, A., and Bloom, A.L.: Lupus anticoagulant: a place for pre-pregnancy treatment? Lancet 2:842–843, 1985.PubMedCrossRefGoogle Scholar
  23. Feinstein, D.I.: Lupus anticoagulant, thrombosis, and fetal loss. N. Engl. I Med. 313:1348–1350, 1985.CrossRefGoogle Scholar
  24. Gleicher, N., and Friberg, I: IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. I A.M. A. 253:3278–3281, 1985.CrossRefGoogle Scholar
  25. Gott, E.: Lupus erythematodes disseminatus: Schwangerschaft und Geburt. Dtsch. Med. Wochenschr. 94: 274–279, 1969.PubMedCrossRefGoogle Scholar
  26. Grennan, D.M., McCormick, I.N., Wojtacha, D., Carty, M., and Behan, W.: Immunological studies of the placenta in systemic lupus erythematosus. Ann. Rheum. Dis. 37:129–134, 1978.PubMedCrossRefGoogle Scholar
  27. Grimes, D.A., LeBolt, S.A., Grimes, K.R., and Wingo, P.A.: Systemic lupus erythematosus and reproductive function: a case-control study. Am. I Obstet. Gynecol. 153:179–186, 1985.Google Scholar
  28. Grimmer, D., Landas, S., and Kemp, I.D.: IgM antitro-phoblast antibodies in a patient with a pregnancy-associated lupuslike disorder, vasculitis, and recurrent intrauterine fetal demise. Arch. Pathol. Lab. Med. 112:191–193, 1988.PubMedGoogle Scholar
  29. Hayslett, J.P., and Reece, E.A.: Systemic lupus erythematosus in pregnancy. Clin. Perinatol. 12:539–549, 1985.PubMedGoogle Scholar
  30. Hulka, J.F.: Discussion of Grimes et al. Am. J. Obstet. Gynecol. 153:185, 1985.Google Scholar
  31. Hull, D., Binns, B.A.O., and Joyce, D.: Congenital heart block and widespread fibrosis due to maternal lupus erythematosus. Arch. Dis. Child. 41:688–690, 1966.PubMedCrossRefGoogle Scholar
  32. Jackson, R.: Discoid lupus in a newborn infant of a mother with lupus erythematosus. Pediatrics 33:425–430, 1964.PubMedGoogle Scholar
  33. Johnson, P.M., Natvig, J.B., Ystehede, U.A., and Faulk, W.P.: Immunological studies on human placentae: the distribution and character of immunoglobulins in chorionic villi. Clin. Exp. Immunol. 30:145–153, 1977.PubMedGoogle Scholar
  34. Klippel, J.H., Grimley, P.M., and Decker, J.L.: Lymphocyte inclusions in newborns of mothers with systemic lupus erythematosus. N. Engl. J. Med. 290: 96–97, 1974.PubMedCrossRefGoogle Scholar
  35. Lazarchick, J., and Kizer, J.: The laboratory diagnosis of lupus anticoagulants. Arch Pathol. Lab. Med. 113: 177–180, 1989.Google Scholar
  36. Lockshin, M.D., Druzin, M.L., and Qamar, T.: Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am. J. Obstet. Gynecol. 160:439–443,1989.PubMedCrossRefGoogle Scholar
  37. Lockwood, C.J., Reece, E.A., Romero, R., and Hobbins, J.C.: Anti-phospholipid antibody and pregnancy wastage. Lancet 2:742–743, 1986.PubMedCrossRefGoogle Scholar
  38. Lockwood, C.J., Romero, R., Feinberg, R.F., Clyne, L.P., Coster, B., and Hobbins, J.C.: The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am. J. Obstet. Gynecol. 161:369–373, 1989.PubMedCrossRefGoogle Scholar
  39. Loizoll, S., Byron, M.A., Englert, H.J., David, J., Hughes, G.R.V., and Walport, M.J.: Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q.J. Med. 525–531, 1988.Google Scholar
  40. Lubbe, W.F., and Liggins, G.C.: Lupus anticoagulant and pregnancy. Am. J. Obstet. Gynecol. 153:322–327, 1985.PubMedGoogle Scholar
  41. Lubbe, W.F., Butler, W.S., Palmer, S.J., and Liggins, G.C.: Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1:1361–1363, 1983.PubMedCrossRefGoogle Scholar
  42. Mäkilä, U.-M., Jouppila, P., Kirkinen, P., Viinikka, L., and Ylikorkala, O.: Placental thromboxane and prostacyclin in the regulation of placental blood flow. Obstet. Gynecol. 68:537–540, 1986.PubMedGoogle Scholar
  43. McVerry, B.A., Machin, S.J., Parry, H., and Goldstone, A.H.: Reduced prostacyclin activity in systemic lupus erythematosus. Ann. Rheum. Dis. 39:524–525, 1980.PubMedCrossRefGoogle Scholar
  44. Mijer, F., and Olsen, R.N.: Transplacental passage of L.E. factor. J. Pediatr. 52:690–693, 1958.PubMedCrossRefGoogle Scholar
  45. Mund, A., Simson, J., and Rothfield, N.: Effect of Pregnancy on course of systemic lupus erythematosus. J.A.M.A. 183:917–920, 1963.PubMedCrossRefGoogle Scholar
  46. Nilsson, I.M., Astedt, B., Hedner, U., and Berezin, D.: Intrauterine death and circulating anticoagulant, “antithromboplastin.” Acta Med. Scand. 197:153–159, 1975.PubMedCrossRefGoogle Scholar
  47. Prentice, R.L., Gatenby, P.A., Loblay, R.H., Shearman, R.P., Kronenberg, H., and Basten, A.: Lupus anticoagulant in pregnancy. Lancet 2:464, 1984.PubMedCrossRefGoogle Scholar
  48. Pritchard, M.H., Jessop, J.D., Trenchard, P.M., and Whiltaker, J.A.: Systemic lupus erythematosus, repeated abortions, and thrombocytopenia. Ann. Rheum. Dis. 37:476–478, 1978.PubMedCrossRefGoogle Scholar
  49. Provost, T.T., Watson, R., Gammon, W.R., Radowsky, M., Harley, J.B., and Reichlin, M.: The neonatal lupus syndrome associated with UxRNP (nRNP) antibodies. N. Engl. J. Med. 316:1135–1138, 1987.PubMedCrossRefGoogle Scholar
  50. Reece, E.A., Romero, R., Clyne, L.P., Kriz, N.S., and Hobbins, J.C.: Lupus-like anticoagulant in pregnancy. Lancet 1:344–345,1984.PubMedCrossRefGoogle Scholar
  51. Rosenberg, A.M., Bingham, M.C., and Fong, K.C.: Antinuclear antibodies during pregnancy. Obstet. Gynecol. 68:560–562, 1986.PubMedGoogle Scholar
  52. Rosove, M.H., Tabsh, K., Wasserstrum, N., Howard, P., Hahn, B.H., and Kalunian, K.C.: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin. Obstet. Gynecol. 73:630–634, 1990.Google Scholar
  53. Rouget, J.P., Goudemand, J., Montreuil, Gl, Cosson, A., and Jaillard, I: Lupus anticoagulant: a familial observation. Lancet 2:105, 1982.PubMedCrossRefGoogle Scholar
  54. Schenker, J.G., Segal, S., and Polishuk, W.Z.: Systemic lupus erythematosus in pregnancy. Harefuah 82:1–4, 1972.Google Scholar
  55. Scott, J.R., Branch, D.W., Kochenour, N.K., and Ward, K.: Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am. J. Obstet. Gynecol. 159:1055–1056, 1988.PubMedGoogle Scholar
  56. Seip, M.: Systemic lupus erythematosus in pregnancy with haemolytic anaemia, leucopenia and thrombocytopenia in the mother and her newborn infant. Arch. Dis. Child. 35:364–366, 1960.PubMedCrossRefGoogle Scholar
  57. Sheridan-Pereira, M., Porreco, R., Hays, T., and Burke, M.S.: Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstet. Gynecol. 71:1016–1018, 1988.PubMedGoogle Scholar
  58. Silver, M.M.: Massive placental infarction due to the lupus anticoagulant. Mod. Pathol. 1:85A, 1988, (abstract 508).Google Scholar
  59. Stormorken, H., Gjemdal, T., and Njoro, K.: Lupus anticoagulant: a unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency. Gynecol. Obstet. Invest. 26:83–88, 1988.PubMedCrossRefGoogle Scholar
  60. Triplett, D.A.: Antiphospholipid antibodies and recurrent pregnancy loss. Am. J. Reprod. Immunol. 20: 52–67, 1989.PubMedCrossRefGoogle Scholar
  61. Triplett, D.A., Brandt, J.T., and Maas, R.L.: The laboratory heterogeneity of lupus anticoagulant. Arch. Pathol. Lab. Med. 109:946–951, 1985.PubMedGoogle Scholar
  62. Trudinger, B.J., Stewart, G.J., Cook, C.M., Connelly, A., and Exner, T.: Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet. Gynecol. 72:215–218, 1988.PubMedGoogle Scholar
  63. Unander, A.M., Norberg, R., Hahn, L., and Arfors, L.: Anticardiolipin antibodies and complement in ninetynine women with habitual abortion. Am. J. Obstet. Gynecol. 156:114–119, 1987.PubMedGoogle Scholar
  64. Wapner, R.J., Cowchock, F.S., and Shapiro, S.S.: Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am. J. Obstet. Gynecol. 161:1271–1272, 1989.PubMedCrossRefGoogle Scholar
  65. Warrell, D.W., and Taylor, R.: Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet 1:117–118, 1968.PubMedCrossRefGoogle Scholar
  66. Woodhouse, S.: The lupus anticoagulant and the dilute Russell viper venom test. Pathologist July:432–433, 1984.Google Scholar
  67. Ylikorkala, O., and Mäkilä, U.-M.: Prostacyclin and thromboxane in gynecology and obstetrics. Am. J. Obstet. Gynecol. 152:318–329, 1985.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Kurt Benirschke
    • 1
    • 2
  • Peter Kaufmann
    • 3
  1. 1.Pathology and Reproductive MedicineUniversity of CaliforniaSan DiegoUSA
  2. 2.University Medical CenterSan DiegoUSA
  3. 3.Institut für Anatomie der Medizinischen Fakultät, Rheinisch-Westfälische TechnischeHochschule AachenAachenGermany

Personalised recommendations